0.76% sodium monofluorophosphate

DRUG5 trials

Sponsors

Procter and Gamble, Colgate Palmolive

Conditions

Calculus, DentalDental HypersensitivityGingivitisOral Malodor

Phase 2

Efficacy of Toothpaste Containing 0.454% Stannous Fluoride as Compared to a Regular Fluoride Toothpaste Containing 0.76% Sodium Monofluorophosphate in Controlling Supragingival Calculus Formation Over a 12-week Period.

CompletedNCT07223060

Colgate PalmoliveCalculus, Dental

Start: 2017-05-17End: 2017-10-06Updated: 2025-12-11

Phase 3

A Clinical Study Conducted in the Bangkok, Thailand Area, to Investigate the Clinical Efficacy of a New Toothpaste

CompletedNCT07223073

Colgate PalmoliveOral Malodor

Start: 2017-12-21End: 2018-01-12Updated: 2025-10-31

Dentin Hypersensitivity Reduction Efficacy Clinical

CompletedNCT07738198

Colgate PalmoliveDental Hypersensitivity

Start: 2018-11-26End: 2018-12-08Updated: 2026-07-31

Unknown Phase

A Bleeding-Model Clinical Study

CompletedNCT05916508

Procter and GambleGingivitis

Start: 2020-10-19End: 2020-11-20Updated: 2023-06-23

A Three Month Bleeding-Model Clinical Study

CompletedNCT05916521

Procter and GambleGingivitis

Start: 2021-11-15End: 2022-02-11Updated: 2023-06-23

Related Papers

Randomized Controlled Trials Assessing Exposure Frequency Effects of Stannous Fluoride on Gingivitis

JDR Clinical & Translational Research2024-08-08